INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,590,662 | -87.5% | 25,121 | -89.3% | 0.01% | -87.2% |
| Q1 2023 | $12,678,085 | +23.4% | 234,129 | +20.6% | 0.04% | +11.4% |
| Q4 2022 | $10,274,524 | -66.3% | 194,152 | -70.4% | 0.04% | -71.3% |
| Q3 2022 | $30,514,000 | +114.0% | 655,800 | +18.0% | 0.12% | +67.1% |
| Q3 2020 | $14,258,000 | +240.9% | 555,643 | -0.8% | 0.07% | +180.8% |
| Q3 2019 | $4,182,000 | +243.3% | 559,900 | +459.9% | 0.03% | +333.3% |
| Q1 2019 | $1,218,000 | -64.4% | 100,000 | -66.7% | 0.01% | -64.7% |
| Q4 2018 | $3,421,000 | -75.2% | 300,352 | -52.7% | 0.02% | -70.2% |
| Q3 2018 | $13,768,000 | +310.4% | 634,466 | +234.2% | 0.06% | +338.5% |
| Q2 2018 | $3,355,000 | -30.9% | 189,857 | -17.6% | 0.01% | -35.0% |
| Q1 2018 | $4,852,000 | -25.5% | 230,494 | -48.8% | 0.02% | -28.6% |
| Q4 2017 | $6,516,000 | +58.4% | 450,000 | +72.6% | 0.03% | +55.6% |
| Q3 2017 | $4,114,000 | +76.1% | 260,700 | +70.1% | 0.02% | +12.5% |
| Q3 2016 | $2,336,000 | -64.5% | 153,300 | -9.5% | 0.02% | -64.4% |
| Q2 2016 | $6,572,000 | +2.5% | 169,300 | -26.6% | 0.04% | -8.2% |
| Q1 2016 | $6,411,000 | -27.4% | 230,600 | +40.4% | 0.05% | -32.9% |
| Q4 2015 | $8,832,000 | +807.7% | 164,200 | +575.7% | 0.07% | +812.5% |
| Q3 2015 | $973,000 | -73.3% | 24,300 | -78.7% | 0.01% | -68.0% |
| Q2 2015 | $3,645,000 | +69.9% | 114,100 | +27.0% | 0.02% | +66.7% |
| Q1 2015 | $2,145,000 | – | 89,823 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |